Intra-Cellular Therapies New York City, NY - 10032

Intra-Cellular Therapies is categorized under Research Services in New York City, NY and active since 2002.

Intra-Cellular Therapies was established in 2002, and today employs 1 to 4, earning Unknown per year. This is a Research Services business, which does work in the B2B market, and is classified as a Research Services, under code number 5417115 by the NAICS.

If you are seeking more information, feel free to contact Sharon Mates, Chief Executive Officer at the company’s single location by writing to 3960 Broadway, New York City, New York NY 10032 or by phoning (212) 923-3344. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Intra-Cellular Therapies
Contact Person: Sharon Mates, Chief Executive Officer
Address: 3960 Broadway, New York City, New York 10032
Phone Number: (212) 923-3344
Website Address: intracellulartherapies.com
Annual Revenue (USD): Unknown
Founded: 2002
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Research Services
SIC Code: 8732
NAICS Code: 5417115
Share This Business:

Intra-Cellular Therapies was started in 2002 to provide professional Research Services under the SIC code 8732 and NAICS code 5417115. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Sharon Mates, Chief Executive Officer for inquiries that concern Intra-Cellular Therapies by calling the company number (212) 923-3344, as your correspondence is most welcome. Additionally, the physical location of the single location of Intra-Cellular Therapies can be found at the coordinates 40.83982,-73.94048 as well as the street address 3960 Broadway in New York City, New York 10032.

For its online presence, you may visit Intra-Cellular Therapies’s website at intracellulartherapies.com and engage with its social media outlets through on Twitter and on Facebook.